Table IDisease-7. Incidence of hepatitis C virus antibody among injecting drug users
|
|
|
|
|
|
|
|
Country |
Year |
Number of IDUs followed |
Number of sero-conversions |
Follow-up in person years |
Incidence rate (per 100 person years) |
|
Reference |
|
|
|
|
|
|
|
|
Germany |
1993-1994 |
19 |
6 |
17.5 |
34.3 |
|
11 |
Italy |
1991-1993 |
106 |
21 |
74.3 |
28.2 |
|
9 |
Italy |
1992-1993 |
34 |
2 |
32.1 |
6.2 |
|
10 |
Italy |
1992-1994 |
12 |
5 |
12.7 |
39.3 |
|
26 |
Netherlands |
1986-1989 |
18 |
17 |
207.8 |
8.2 |
|
22 |
Slovakia |
|
623 |
na |
na |
10 |
|
2 |
Sweden |
1990-1993 |
48 |
27 |
103 |
26.3 |
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sources: |
|
|
|
|
|
|
|
All data except for Slovak Republic were taken from: Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect 2002; 129: 577-585. |
|
|
For references see [Table IDisease-0 Part (i)] |
|
|
|
|
|
|
|
|
|
|